COSCIENS Biopharma Inc.

NASDAQ: CSCI · Real-Time Price · USD
2.86
-0.03 (-1.04%)
At close: Aug 19, 2025, 11:55 AM

COSCIENS Biopharma Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
9.13M 7.14M 14.57M 13.49M
Cost of Revenue
4.86M 4.21M 6.02M 5.28M
Gross Profit
4.73M 2.94M 8.56M 8.21M
Operating Income
-18.28M -4.63M 4.32M 2.43M
Interest Income
441K 59K 145K n/a
Pretax Income
-15.22M -4.37M 4.53M 2.59M
Net Income
-15.31M -3.48M 3.45M 2.64M
Selling & General & Admin
10.45M 5.53M 2.87M 2.58M
Research & Development
8.3M 2.04M 1.37M 3.04M
Other Expenses
4.26M n/a n/a 162.26K
Operating Expenses
23.01M 7.57M 4.24M 5.78M
Interest Expense
129K 136K 143K 119.13K
Selling & Marketing Expenses
n/a 30.52K 21.78K 36.95K
Cost & Expenses
27.87M 11.77M 10.25M 11.06M
Income Tax Expense
84K -885K 1.08M -52.92K
Shares Outstanding (Basic)
2.58M 1.85M 1.84M 1.83M
Shares Outstanding (Diluted)
2.58M 1.85M 1.85M 1.85M
EPS (Basic)
-5.93 -1.89 2.51 1.69
EPS (Diluted)
-5.93 -1.89 2.50 1.69
EBITDA
-13.49M -2.84M 6.14M 4.18M
EBIT
-15.1M -4.23M 4.67M 2.71M
Depreciation & Amortization
1.61M 1.44M 1.47M 1.48M